Focus on Minimizing Post-Surgical Adhesion Complications Drives Demand for Anti-Adhesion Products, According to New Report by Global Industry Analysts, Inc.
GIA announces the release of a comprehensive global report on Anti-Adhesion Products markets. Global market for Anti-Adhesion Products is projected to reach US$2.1 billion by 2020, driven by the growing focus on reducing the economic cost and healthcare burden caused by post-surgical adhesion complications.
San Jose, California (PRWEB) July 03, 2014
Follow us on LinkedIn. – Post-surgical tissue adhesion is often the result of the formation of scar tissue between tissues and organs. These adhesions are common in abdominal surgeries, cardiovascular procedures and orthopedic surgeries. Majority of the patients who undergo surgery suffer from adhesions and adhesion related disorders. The intensity of problems created by adhesion depends on factors such as density, location, tenacity and size of the scar tissue. Anti-adhesion products help in reducing post-operative adhesions by forming a mechanical obstruction between organs and internal tissues. The market is expected to witness steady growth supported by growing concerns over adhesion complications and increase in surgical procedures performed globally. With over 25 million surgical procedures performed annually, the potential for prophylactic anti-adhesion treatment remains huge. In the United States and Europe alone, over 1.6 million surgical procedures are undertaken annually to lyse adhesions often causing severe clinical complications ranging from small bowel obstruction to infertility. The escalation in healthcare costs associated with these repeat surgeries is throwing the spotlight on adhesive prevention products.
The use of adhesion prevention products is becoming a standard in cardiovascular surgeries, given its ability to prevent sternum adhesion after cardiac surgery. The rise in cardiovascular diseases as a result of unhealthy lifestyles and poor eating habits and the ensuing rise in cardiac surgeries performed annually are therefore expected to benefit market growth. Increasing prevalence of high cholesterol, hypertension, rising stress, juvenile obesity, and alcohol abuse will continue to indirectly drive gains for anti-adhesion agents in the field of cardiology. Abdominal adhesion barrier products are also gaining favor, owing to the innate vulnerability of abdomen surgeries to adhesion. Abdomen surgeries inclusive of hernia, gastric surgeries, and appendix have shown to be particularly prone to adhesion formation. Abdominal organs are prone to developing both spontaneous and post-surgical adhesions. Intestinal obstruction, abdominal pain, and small bowel obstruction (SBO) represent few of the medical emergencies caused by adhesions.
Joint adhesion prevention products are gaining in prominence supported by rising number of age-related joint replacement surgeries performed globally. The aging population, which accounts for about 10% of the total global population and about 20% of the total population in developed countries, is fast becoming a tidal force fuelling the surge in knee, joint and hip replacement surgeries worldwide. Knee surgeries often result in the formation of adhesion across the knee joint walls resulting in the formation of progressively thickening scar bands causing knee stiffness also referred to as arthofibrosis. The need to prevent postoperative problems in mobility as result of scar tissue formation is spurring the use of anti-adhesion products.
As stated by the new market research report on Anti-Adhesion Products, the United States represents the largest market worldwide. Asia-Pacific ranks as the fastest growing market with a CAGR of 10.4% over the analysis period. General/abdominal surgery represents the largest application area, while pelvic/gynecological surgery is forecast to emerge as the fastest growing end-use market.
Major players covered in the report include Anika Therapeutics Inc., Baxter Healthcare Ltd., Covidien, Ethicon Inc., FzioMed Inc., Integra LifeSciences Corporation, Magen OrthoMed Ltd., MAST Biosurgery AG, and Sanofi UK, among others.
The research report titled “Anti-Adhesion Products: A Global Strategic Business Report”, announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections for all major geographic markets including the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific, Latin-America and Rest of World. The global and regional markets are also analyzed by applications areas, such as General/Abdominal Surgery, Pelvic/Gynecological Surgery, and Others (Include Cardiothoracic Surgery, ENT, and Spine/Neurology Surgery).
For more details about this comprehensive market research report, please visit http://www.strategyr.com/Anti_Adhesion_Products_Market_Report.asp.
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/
For the original version on PRWeb visit: http://www.prweb.com/releases/anti_adhesion_products/joint_adhesion_prevention/prweb11995166.htm